Barriers to pharmacist prescribing: a scoping review comparing the UK, New Zealand, Canadian and Australian experiences.
independent prescribing
non-medical prescribing
prescriptions
primary care
secondary care
Journal
The International journal of pharmacy practice
ISSN: 2042-7174
Titre abrégé: Int J Pharm Pract
Pays: England
ID NLM: 9204243
Informations de publication
Date de publication:
Dec 2019
Dec 2019
Historique:
received:
03
12
2018
revised:
07
05
2019
accepted:
03
06
2019
pubmed:
10
7
2019
medline:
28
3
2020
entrez:
10
7
2019
Statut:
ppublish
Résumé
Non-medical prescribers, including pharmacists, have been found to achieve comparable clinical outcomes with doctors for certain health conditions. Legislation supporting pharmacist prescribing (PP) has been implemented in the United Kingdom (UK), Canada and New Zealand (NZ); however, to date, Australian pharmacists have not been extended prescribing rights. The purpose of this review was to describe the barriers to PP found in the literature from the UK, Canada, NZ and Australia, and examine the implications of these for the development of PP in Australia. We conducted a scoping review, which included peer-reviewed and grey literature, and consultation with stakeholders. Sources - Scopus, PubMed and CINAHL; Google Scholar, OpenGrey and organisational websites from January 2003 to March 2018 in the UK, Canada, NZ and Australia. Inclusion criteria - articles published in English, related to implementation of PP and articulated barriers to PP. Of 863 unique records, 120 were reviewed and 64 articles were eligible for inclusion. Three key themes emerged: (1) Socio-political context, (2) Resourcing issues and (3) Prescriber competence. The most common barriers were inadequate training regarding diagnostic knowledge and skills, inadequate support from authorities and stakeholders, and insufficient funding/reimbursement. If implementation of PP is to occur, attention needs to be focused on addressing identified barriers to PP implementation, including fostering a favourable socio-political context and prescriber competence. As such, a concerted effort is required to develop clear policy pathways, including targeted training courses, raising stakeholder recognition of PP and identifying specific funding, infrastructure and resourcing needs to ensure the smooth integration of pharmacist prescribers within interprofessional clinical teams.
Types de publication
Comparative Study
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
479-489Informations de copyright
© 2019 Royal Pharmaceutical Society.
Références
McPhail SM. Multimorbidity in chronic disease: impact on health care resources and costs. Risk Manag Healthc Policy 2016; 9: 143.
Findlay T, Yen L. Inquiry into Chronic Disease Prevention and Management in Primary Health Care. Canberra: Australia National University. http://ruralhealth.org.au/sites/default/files/documents/nrha-policy-document/submissions/inquiry-chronic-disease-prevention-and-management-primary-health-care.pdf (accessed 10 September 2018).
Bhanbhro S et al. Assessing the contribution of prescribing in primary care by nurses and professionals allied to medicine: a systematic review of literature. BMC Health Serv Res 2011; 11: 330.
Cooper RJ et al. Nurse and pharmacist supplementary prescribing in the UK-a thematic review of the literature. Health Policy 2008; 85: 277-292.
Gerard K et al. Valuing the extended role of prescribing pharmacist in general practice: results from a discrete choice experiment. Value in Health 2012; 15: 699-707.
Cope LC et al. Non-medical prescribing: where are we now? Ther Adv Drug Saf 2016; 7: 165-172.
Weeks G et al. Non-medical prescribing versus medical prescribing for acute and chronic disease management in primary and secondary care. Cochrane Database Syst Rev 2016; (11): article number CS011227.
Stewart D. Pharmacist prescribing: a view from the UK. J Pharm Policy Pract 2009; 39: 7-10.
Stewart D et al. Educating nonmedical prescribers. Br J Clin Pharmacol 2012; 74: 662-667.
Hoti K et al. An expanded prescribing role for pharmacists - an Australian perspective. Australas Med J 2011; 4: 236-242.
Raghunandan R et al. Non-medical prescribing in New Zealand: an overview of prescribing rights, service delivery models and training. Ther Adv Drug Saf 2017; 8: 349-360.
Dawoud D et al. Pharmacist supplementary prescribing: a step toward more independence? Res Social Adm Pharm 2011; 7: 246-256.
Law MR et al. Independent pharmacist prescribing in Canada. Can Pharm J 2012; 145: 17-23.
Canadian Pharmacists Association (2016) Pharmacists' Scope of Practice in Canada. https://www.pharmacists.ca/cpha-ca/assets/File/pharmacy-in-canada/Scope%20of%20Practice%20in%20Canada_JAN2016.pdf (accessed 16 August 2018).
Adams AJ, Weaver KK. The continuum of pharmacist prescriptive authority. Ann Pharmacother 2016; 50: 778-784.
Australia Health Workforce. Health Professionals Prescribing Pathway (HPPP) Project - Final Report. Adelaide: Health Workforce Australia, 2013. https://www.aims.org.au/documents/item/400 (accessed 16 August 2018).
Pharmaceutical Society of Australia. Professional Practice Standards Version 3. Canberra, ACT: Pharmaceutical Society of Australia, 2006.
The Pharmacy Guide of Australia. (2014). Community pharmacy roadmap program development template Australia, The pharmacy guild of Australia. https://www.guild.org.au/__data/assets/pdf_file/0021/5655/medication-adherence-programs.pdf (accessed 16 August 2018).
Kay OC et al. Pharmacist prescribing activities-an electronic survey on the opinions of Australian pharmacists. J Pharm Pract Res 2006; 36: 199-203.
Allison Y. Pharmacist prescribing in Australia. Australas J Pharm 2010; 91: 29.
Hoti K et al. An evaluation of Australian pharmacists’ attitudes on expanding their prescribing role. Pharm World Sci 2010; 32: 610-621.
Hale A et al. Patient satisfaction from two studies of collaborative doctor-pharmacist prescribing in Australia. Health Expect 2016; 19: 49-61.
Hoti K et al. Pharmacy clients' attitudes to expanded pharmacist prescribing and the role of agency theory on involved stakeholders. Int J Pharm Pract 2011; 19: 5-12.
Marotti S et al. A randomised controlled trial of pharmacist medication histories and supplementary prescribing on medication errors in postoperative medications. Anaesth Intensive Care 2011; 39: 1064.
Hale AR et al. Perioperative medication management: expanding the role of the preadmission clinic pharmacist in a single centre, randomised controlled trial of collaborative prescribing. BMJ Open 2013; 3: e003027.
Ung E et al. Assessing pharmacists' readiness to prescribe oral antibiotics for limited infections using a case-vignette technique. Int J Clin Pharm 2017; 39: 61-69.
Hanna T et al. Using scenarios to test the appropriateness of pharmacist prescribing in asthma management. Pharm Pract (Granada) 2014; 12: 390.
Hoti K et al. Identifying the perceived training needs for Australian pharmacist prescribers. Int J Pharm Pract 2014; 22: 38-46.
Kamarudin G et al. Preparing hospital pharmacists to prescribe: stakeholders' views of postgraduate courses. Int J Pharm Pract 2013; 21: 243-251.
Hoti K et al. Expanded prescribing: a comparison of the views of Australian hospital and community pharmacists. Int J Pharm Pract 2013; 35: 469-475.
Arksey H, O'Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol 2005; 8: 19-32.
Joanna Briggs Institute. Why a scoping review? Joanna Briggs Institute. https://wiki.joannabriggs.org/pages/viewpage.action?pageId=3178748 (accessed 10 September 2018).
Anderson S et al. Asking the right questions: scoping studies in the commissioning of research on the organisation and delivery of health services. Health Res Policy Syst 2008; 6: 7.
Merriam-Webster.Secondary care. Springfield, MA. Merriam Webster Incorporated. https://www.merriam-webster.com/dictionary/secondary%20care (accessed 10 September 2018).
Merriam-Webster. Primary care. Springfield, MA: Merriam Webster Incorporated. https://www.merriam-webster.com/dictionary/primary%20care (accessed 10 September 2018).
Stewart DC et al. Exploring patients’ perspectives of pharmacist supplementary prescribing in Scotland. Int J Clin Pharm 2008; 30: 892-897.
Lloyd F et al. ‘It's showed me the skills that he has’: pharmacists' and mentors' views on pharmacist supplementary prescribing. Int J Pharm Pract 2010; 18: 29-36.
Stewart DC et al. Pharmacist prescribing in primary care: the views of patients across Great Britain who had experienced the service. Int J Pharm Pract 2011; 19: 328-332.
Gumber R et al. Non-medical prescribing: audit, practice and views. J Psychiatr Ment Health Nurs 2012; 19: 475-481.
Courtenay M et al. An overview of non medical prescribing across one strategic health authority: a questionnaire survey. BMC Health Serv Res 2012; 12: 138.
Hill DR et al. Stakeholder views on pharmacist prescribing in addiction services in NHS Lanarkshire. J Subst Use 2014; 19: 56-67.
Mulholland PJ. Pharmacists as non-medical prescribers: what role can they play? The experience in a neonatal intensive care unit. Eur J Hosp Pharm Sci Pract 2014; 21: 335-338.
Bourne RS et al. Pharmacist independent prescribing in secondary care: opportunities and challenges. Int J Clin Pharm 2016; 38: 1-6.
McIntosh T, Stewart D. A qualitative study of UK pharmacy pre-registration graduates' views and reflections on pharmacist prescribing. Int J Pharm Pract 2016; 24: 139-141.
General Pharmaceutical Council. Prescribers survey report. In: General Pharmaceutical Council, editor. London: General Pharmaceutical Council; 2016.
George J et al. Supplementary prescribing: early experiences of pharmacists in Great Britain. Ann Pharmacother 2006; 40: 1843-1850.
George J et al. Benefits and challenges of prescribing training and implementation: perceptions and early experiences of RPSGB prescribers. Int J Pharm Pract 2007; 15: 23-30.
Grindrod KA et al. Pharmacy owner and manager perceptions of pharmacy adaptation services in British Columbia. Can Pharm J (Ott) 2011; 144: 231-235.
Henrich N et al. Family physicians' perceptions of pharmacy adaptation services in British Columbia. Can Pharm J (Ott) 2011; 144: 172-178.
Perepelkin J. Public opinion of pharmacists and pharmacist prescribing. Can Pharm J (Ott) 2011; 144: 86-93.
Pojskic N et al. Initial perceptions of key stakeholders in Ontario regarding independent prescriptive authority for pharmacists. Res Social Adm Pharm 2014; 10: 341-354.
Rosenthal MM et al. Prescribing by pharmacists in Alberta and its relation to culture and personality traits. Res Social Adm Pharm 2015; 11: 401-411.
Isenor JE et al. Identification of the relationship between barriers and facilitators of pharmacist prescribing and self-reported prescribing activity using the theoretical domains framework. Res Social Adm Pharm 2018; 14: 784-791.
Schindel TJ, Given LM. The pharmacist as prescriber: a discourse analysis of newspaper media in Canada. Res Social Adm Pharm 2013; 9: 384-395.
Hatah E et al. General practitioners' perceptions of pharmacists' new services in New Zealand. Int J Clin Pharm 2012; 34: 364-373.
Hatah E et al. General practitioners' views of pharmacists' current and potential contributions to medication review and prescribing in New Zealand. J Prim Health Care 2013; 5: 223-233.
Weeks GR et al. Australian hospital pharmacists' experiences of a UK non-medical prescribing course. J Pharm Pract Res 2010; 40: 187-193.
Governance Institute of Australia (2018). What is Governance? Sydney: Governance Institute of Australia. https://www.governanceinstitute.com.au/resources/what-is-governance/ (accessed 10 September 2018).
Hobson RJ et al. Pharmacists and nurses as independent prescribers: exploring the patient's perspective. Fam Pract 2009; 27: 110-120.
Stewart DC et al. Cross sectional survey of the Scottish general public's awareness of, views on, and attitudes toward nonmedical prescribing. Ann Pharmacother 2009; 43: 1115-1121.
Courtenay M et al. Non medical prescribing leads views on their role and the implementation of non medical prescribing from a multi-organisational perspective. BMC Health Serv Res 2011; 11: 142.
Lim RHM et al. Roles of the non-medical prescribing leads within organisations across a Strategic Health Authority: perceived functions and factors supporting the role. Int J Pharm Pract 2013; 21: 82-91.
Hobson RJ, Sewell GJ. Supplementary prescribing by pharmacists in England. Am J Health Syst Pharm 2006; 63: 244-253.
Dapar MP. An Investigation of the Structures and Processes of Pharmacist Prescribing in Great Britain: A Mixed Methods Approach. Scotland: Robert Gordon University, 2012.
Avery AJ, Pringle M. Extended prescribing by UK nurses and pharmacists: with more evidence and strict safeguards, it could benefit patients. BMJ 2005; 331: 1154.
Hutchison M et al. Survey of Alberta hospital pharmacists' perspectives on additional prescribing authorization. Am J Health Syst Pharm 2012; 69: 1983-1992.
British Columbia Pharmacy Association.2017 Adapting Prescriptions: Addressing Perceived Barriers To Allow For More Creative And Effective Patient Care. Vancouver, BC: British Columbia Pharmacy Association. https://www.bcpharmacy.ca/news/adapting-prescriptions-addressing-perceived-barriers-allow-more-creative-and-effective-patient(accessed 16 August 2018).
Australian Medical Association (2018). Pharmacist prescribing - what the AMA thinks. Australian Medical Association. https://ama.com.au/ausmed/pharmacist-prescribing-%E2%80%93-what-ama-thinks(accessed 10 September 2018).
Cooper R et al. Stakeholders’ views of UK nurse and pharmacist supplementary prescribing. J Health Serv Res Policy 2008; 13: 215-221.
Cooper RJ et al. Further challenges to medical dominance? The case of nurse and pharmacist supplementary prescribing. Health 2012; 16: 115-133.
McCann LM et al. A patient perspective of pharmacist prescribing:‘crossing the specialisms-crossing the illnesses’. Health Expect 2015; 18: 58-68.
Bissell P et al. An evaluation of supplementary prescribing in nursing and pharmacy. Final report for the Department of Health. University of Sheffield, 2008.
Wheeler A et al. Collaborative prescribing: a qualitative exploration of a role for pharmacists in mental health. Res Social Adm Pharm 2012; 8: 179-192.
Blenkinsopp A et al. Opportunity or threat? General practitioner perceptions of pharmacist prescribing. Int J Pharm Pract 2008; 16: 29-34.
MacLure K et al. Views of the Scottish general public on non-medical prescribing. Int J Clin Pharm 2013; 35: 704-710.
Ockelford P. 2012 Proposed Schedule of Medicines and Controlled Drugs for Designated Prescriber/Pharmacist Prescriber. New Zealand: New Zealand Medical Association. https://www.nzma.org.nz/__data/assets/pdf_file/0019/1594/Pharmacistprescribers-sub.pdf (accessed 10 September 2018).
Lloyd F, Hughes CM. Pharmacists' and mentors' views on the introduction of pharmacist supplementary prescribing: a qualitative evaluation of views and context. Int J Pharm Pract 2007; 15: 31-37.
McCann L et al. "They come with multiple morbidities": a qualitative assessment of pharmacist prescribing. J Interprof Care 2012; 26: 127-33.
Weiss MC, Sutton J. The changing nature of prescribing: pharmacists as prescribers and challenges to medical dominance. Sociol Health Illn. 2009; 31: 406-421.
McCann L et al. Pharmacist prescribing in Northern Ireland: a quantitative assessment. Int J Clin Pharm 2011; 33: 824-831.
Hobson RJ. Investigation into early implementation of non medical prescribing in the UK.University of Bath, 2008.
Makowsky MJ et al. Factors influencing pharmacists' adoption of prescribing: qualitative application of the diffusion of innovations theory. Implement Sci 2013; 8: 109. https://doi.org/10.1186/1748-5908-8-109
Nissen L, Kyle G. Non-medical prescribing in Australia. Aust Prescr 2010; 33: 166-167.
Bhatia Set al. Provincial comparison of pharmacist prescribing in Canada using Alberta's model as the reference point. Can J Hosp Pharm 2017; 70: 349-357.
Tannenbaum C, Tsuyuki RT. The expanding scope of pharmacists' practice: Implications or physicians. CMAJ 2013; 185: 1228-1232.
Hughes CA et al. Positioning pharmacists’ roles in primary health care: a discourse analysis of the compensation plan in Alberta, Canada. BMC Health Serv Res 2017; 17: 770. https://doi.org/10.1186/s12913-017-2734-x
Bishop AC et al. Public perceptions of pharmacist expanded scope of practice services in Nova Scotia. Can Pharm J (Ott) 2015; 148: 274-283.
Famiyeh I-M. Pharmacy Service Users’ Support for and Willingness to use community pharmacist prescribing services in Ontario. Toronto: University of Toronto, 2017.
Buckley P et al. Inter and intra-professional perspectives on non-medical prescribing in an NHS trust. Pharm J 2006; 277: 394-398.
Hobson RJ, Sewell GJ. Risks and concerns about supplementary prescribing: survey of primary and secondary care pharmacists. Pharm World Sci 2006; 28: 76-90.
Bryant L et al. Changing perspectives of the role of community pharmacists: 1998-2012. J Prim Health Care 2017; 9: 34-46.
New Zealand Medical Association. (2011). Pharmacist prescribing rights. New Zealand: New Zealand Medical Association. https://www.nzma.org.nz/__data/assets/pdf_file/0012/17400/vitalsigns557.pdf (accessed 10 September 2018).
George J et al. Independent prescribing by pharmacists: a study of the awareness, views and attitudes of Scottish community pharmacists. Pharm World Sci 2006; 28: 45-53.
Morris S, Coombes I. The right to prescribe: towards core prescribing competencies for all prescribers. Aust Prescr 2011; 34: 126-127.
Australian Medical Association (2016). Bigger risk, no reward, in expanding pharmacist scope. Australian Medical Association. https://ama.com.au/ausmed/bigger-risk-no-reward-expanding-pharmacist-scope (accessed 10 September 2018).
Stewart D et al. Non-medical prescribers and pharmacovigilance: participation, competence and future needs. Int J Clin Pharm 2013; 35: 268-274.
Foley P. Proposed Pharmacist Prescriber Scope of Practice. New Zealand: New Zealand Medical Association, 2010: https://www.nzma.org.nz/__data/assets/pdf_file/0016/1843/sub_pharmacyprescribing.pdf (accessed 10 September 2018).
Maddox C et al. Factors influencing nurse and pharmacist willingness to take or not take responsibility for non-medical prescribing. Res Social Adm Pharm 2016; 12: 41-55.
McIntosh T et al. Influences on prescribing decision-making among non-medical prescribers in the United Kingdom: systematic review. Fam Pract 2016; 33: 572-579.
Abuzour AS et al. Practice makes perfect: a systematic review of the expertise development of pharmacist and nurse independent prescribers in the United Kingdom. Res Social Adm Pharm 2018; 14: 6-17.
Schindel TJ et al. Perceptions of pharmacists' roles in the era of expanding scopes of practice. Res Social Adm Pharm 2017; 13: 148-161.
Heck T et al. Independent prescribing by hospital pharmacists: patterns and practices in a Canadian province. Am J Health Syst Pharm 2015; 72: 2166-2175.
Nugus P et al. How and where clinicians exercise power: Interprofessional relations in health care. Soc Sci Med 2010; 71: 898-909.
Le PP et al. Collaborative pharmacist prescribing within the opioid substitution treatment program in South Australia: patient and pharmacist views. Res Social Adm Pharm 2018; 14: 187-195.
Australian Government. The National Health (Collaborative arrangements for nurse practitioners) Determination 2010. In: Australian Government, editor. Canberra, 2010.
Australian Government. Collaborative Arrangements for Participating Midwives and Nurse Practitioners: Fact Sheet.Canberra: Australian Government, 2010: http://www.health.gov.au/internet/main/publishing.nsf/content/6BA6089D02F1E2DACA257BF000204422/$File/collaborative.pdf (accessed 10 September 2018).
Res R et al. Pharmacists' perceptions regarding optimization of antibiotic prescribing in the community. J Pharm Pract 2017; 30: 146-153.
Rosen R, Mountford L. Developing and supporting extended nursing roles: the challenges of NHS walk-in centres. J Adv Nurs 2002; 39: 241-248.
Mills J, Hallinan C. The social world of Australian practice nurses and the influence of medical dominance: an analysis of the literature. Int J Nurs Pract 2009; 15: 489-494.
Phillips C et al. Time to talk, time to see: changing microeconomies of professional practice among nurses and doctors in Australian general practice. Contemp Nurse 2007; 26: 136-144.
Cashin A. The challenge of nurse innovation in the Australian context of universal health care. Collegian 2015; 22: 319-324.